300 related articles for article (PubMed ID: 18559505)
1. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Cowden Dahl KD; Symowicz J; Ning Y; Gutierrez E; Fishman DA; Adley BP; Stack MS; Hudson LG
Cancer Res; 2008 Jun; 68(12):4606-13. PubMed ID: 18559505
[TBL] [Abstract][Full Text] [Related]
2. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Cowden Dahl KD; Zeineldin R; Hudson LG
Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
[TBL] [Abstract][Full Text] [Related]
3. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
[TBL] [Abstract][Full Text] [Related]
4. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
Moss NM; Liu Y; Johnson JJ; Debiase P; Jones J; Hudson LG; Munshi HG; Stack MS
Mol Cancer Res; 2009 Jun; 7(6):809-20. PubMed ID: 19509114
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.
Cheng JC; Klausen C; Leung PC
Mol Endocrinol; 2010 Aug; 24(8):1569-80. PubMed ID: 20610539
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG
Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738
[TBL] [Abstract][Full Text] [Related]
8. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
Cheng JC; Chang HM; Leung PC
Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
11. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells.
Cheng JC; Qiu X; Chang HM; Leung PC
Biochem Biophys Res Commun; 2013 Apr; 434(1):81-6. PubMed ID: 23542467
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.
Rea K; Roggiani F; De Cecco L; Raspagliesi F; Carcangiu ML; Nair-Menon J; Bagnoli M; Bortolomai I; Mezzanzanica D; Canevari S; Kourtidis A; Anastasiadis PZ; Tomassetti A
J Exp Clin Cancer Res; 2018 Jul; 37(1):146. PubMed ID: 29996940
[TBL] [Abstract][Full Text] [Related]
13. AP-2α suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin.
Zhang Z; Zhang L; Jia L; Cui S; Shi Y; Chang A; Zeng X; Wang P
Mol Cell Biochem; 2013 Sep; 381(1-2):31-9. PubMed ID: 23660954
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Alshenawy HA
Ann Diagn Pathol; 2010 Dec; 14(6):387-95. PubMed ID: 21074685
[TBL] [Abstract][Full Text] [Related]
15. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Zhang K; Chen D; Jiao X; Zhang S; Liu X; Cao J; Wu L; Wang D
Lab Invest; 2011 Mar; 91(3):426-38. PubMed ID: 21283078
[TBL] [Abstract][Full Text] [Related]
16. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
Xue L; Su D; Li D; Gao W; Yuan R; Pang W
Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.
Miotti S; Tomassetti A; Facetti I; Sanna E; Berno V; Canevari S
Am J Pathol; 2005 Nov; 167(5):1411-27. PubMed ID: 16251425
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
20. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
